Literature DB >> 16542216

Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study.

Naoki Nakaya1, Kumi Saito-Nakaya, Nobuya Akizuki, Eisho Yoshikawa, Makoto Kobayakawa, Maiko Fujimori, Kanji Nagai, Yutaka Nishiwaki, Shin Fukudo, Yoshitaka Tsubono, Yosuke Uchitomi.   

Abstract

Psychological depression is thought to be a predictor of poor survival among cancer patients. The objective of the present study was to investigate the association between depression and survival in surgically treated Japanese patients with non-small cell lung cancer (NSCLC). From June 1996 through April 1999, a total of 229 patients with postoperative lung cancer were enrolled. Three months after the patients' surgery, the Structured Clinical Interview for DSM-III-R (SCID) and the Profile of Mood States (POMS) were used to assess the patient for depression, based on the interviewers' rating and a self-report, respectively. The follow-up period consisted of a total of 14 342 person-months (median=69 months). As of January 2004, 55 deaths had occurred within the follow-up period. A Cox regression was used to estimate the hazard ratio (HR) of mortality adjusting for age, sex, smoking status, occasion of diagnosis, pathological stage and preoperative percentage forced expiratory volume in 1 s. The depression-dejection subscale on the POMS was divided into three score levels. The multivariate HR of survival for individuals with depression, as diagnosed by the SCID, was 2.2 (95% confidence interval 0.8-6.0) (P-value=0.14), compared with individuals without depression. The multivariate HR of survival for subjects in the highest level of the POMS Depression-Dejection subscale was 1.4 (0.7-2.6), compared with in the lowest level (trend P-value=0.0502). This prospective cohort study in Japan does not support the hypothesis that depression is associated with survival among NSCLC patients after curative resection, but further analysis involving a long-term follow-up period is needed.

Entities:  

Mesh:

Year:  2006        PMID: 16542216     DOI: 10.1111/j.1349-7006.2006.00160.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  12 in total

1.  Depressive symptoms during the first chemotherapy cycle predict mortality in patients with advanced non-small cell lung cancer.

Authors:  Mei-Ling Chen; Min-Chi Chen; Chih-Teng Yu
Journal:  Support Care Cancer       Date:  2010-09-14       Impact factor: 3.603

2.  Impact of postdiagnosis smoking on long-term survival of cancer patients: the Shanghai cohort study.

Authors:  Li Tao; Renwei Wang; Yu-Tang Gao; Jian-Min Yuan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12       Impact factor: 4.254

3.  Coping strategies and depressive symptoms in cancer patients.

Authors:  I Ghanem; B Castelo; P Jimenez-Fonseca; A Carmona-Bayonas; O Higuera; C Beato; T García; R Hernández; C Calderon
Journal:  Clin Transl Oncol       Date:  2019-05-10       Impact factor: 3.405

4.  Race by sex differences in depression symptoms and psychosocial service use among non-Hispanic black and white patients with lung cancer.

Authors:  Lara Traeger; Sheila Cannon; Nancy L Keating; William F Pirl; Christopher Lathan; Michelle Y Martin; Yulei He; Elyse R Park
Journal:  J Clin Oncol       Date:  2013-12-09       Impact factor: 44.544

5.  Effects of nutritional and psychological status of the patients with advanced stomach cancer on physical performance status.

Authors:  Jun Tian; Zhen-chun Chen; Li-Fang Hang
Journal:  Support Care Cancer       Date:  2009-01-27       Impact factor: 3.603

6.  Depression and cancer mortality: a meta-analysis.

Authors:  M Pinquart; P R Duberstein
Journal:  Psychol Med       Date:  2010-01-20       Impact factor: 7.723

7.  Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look.

Authors:  Lucie Opatrny; J A 'chris' Delaney; Samy Suissa
Journal:  Br J Clin Pharmacol       Date:  2008-05-06       Impact factor: 4.335

8.  Effects of nutritional and psychological status in gastrointestinal cancer patients on tolerance of treatment.

Authors:  Jun Tian; Zhen-Chun Chen; Li-Fang Hang
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

9.  Depressive symptoms and cytokine levels in Serum and Tumor Tissue in patients with an Astrocytoma: a pilot study.

Authors:  Angela R Starkweather; Paula Sherwood; Debra E Lyon; Dana H Bovbjerg; William C Broaddus; R K Elswick; Jamie Sturgill
Journal:  BMC Res Notes       Date:  2014-07-04

10.  Chemotherapeutic Response and Prognosis among Lung Cancer Patients with and without Depression.

Authors:  Jue Chen; Weichun Li; Lin Cui; Yayun Qian; Yaodong Zhu; Hao Gu; Gaoyang Chen; Yi Shen; Yanqing Liu
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.